EXORPHINASE Trademark

Trademark Overview

On Wednesday, January 25, 2017, a trademark application was filed for EXORPHINASE with the United States Patent and Trademark Office. The USPTO has given the EXORPHINASE trademark a serial number of 87313098. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 2, 2024. This trademark is owned by ProThera, Inc.. The EXORPHINASE trademark is filed in the Pharmaceutical Products category with the following description:

Enzymes sold as an ingredient of dietary supplements; Enzymes sold as an ingredient of dietary supplements for humans and animals
exorphinase

General Information

Serial Number87313098
Word MarkEXORPHINASE
Filing DateWednesday, January 25, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 2, 2024
Registration Number5368190
Registration DateTuesday, January 2, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2017

Trademark Statements

Goods and ServicesEnzymes sold as an ingredient of dietary supplements; Enzymes sold as an ingredient of dietary supplements for humans and animals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 28, 2017
Primary Code005
First Use Anywhere DateWednesday, November 17, 1999
First Use In Commerce DateWednesday, November 17, 1999

Trademark Owner History

Party NameProThera, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressReno, NV 89521
Party NameProThera, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressReno, CA 89521
Party NameProThera, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressReno, CA 89521

Trademark Events

Event DateEvent Description
Tuesday, February 14, 2017NON-FINAL ACTION WRITTEN
Saturday, January 28, 2017NEW APPLICATION ENTERED
Saturday, January 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 14, 2017ASSIGNED TO EXAMINER
Tuesday, February 14, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2017NON-FINAL ACTION E-MAILED
Thursday, August 10, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 10, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 15, 2017FINAL REFUSAL WRITTEN
Friday, September 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2017FINAL REFUSAL E-MAILED
Tuesday, August 15, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 24, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 6, 2017ASSIGNED TO LIE
Friday, September 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 14, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 28, 2023TEAS SECTION 8 & 15 RECEIVED
Friday, August 2, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 2, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, July 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 2, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

exorphinase supplements enzymes dietary ingredient sold animals humans